1. Home
  2. PSNY vs STOK Comparison

PSNY vs STOK Comparison

Compare PSNY & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polestar Automotive Holding UK PLC ADS

PSNY

Polestar Automotive Holding UK PLC ADS

HOLD

Current Price

$12.59

Market Cap

1.8B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.87

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSNY
STOK
Founded
2017
2014
Country
Sweden
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PSNY
STOK
Price
$12.59
$32.87
Analyst Decision
Hold
Strong Buy
Analyst Count
1
9
Target Price
N/A
$33.11
AVG Volume (30 Days)
322.2K
938.4K
Earning Date
09-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.68
Revenue
$2,547,619,000.00
$205,632,000.00
Revenue This Year
$49.69
$430.24
Revenue Next Year
$44.50
N/A
P/E Ratio
N/A
$46.63
Revenue Growth
24.82
1128.17
52 Week Low
$11.75
$5.35
52 Week High
$42.60
$38.69

Technical Indicators

Market Signals
Indicator
PSNY
STOK
Relative Strength Index (RSI) 67.78 54.65
Support Level $11.75 $31.50
Resistance Level $14.87 $34.05
Average True Range (ATR) 1.31 2.24
MACD 0.63 -0.04
Stochastic Oscillator 66.41 50.15

Price Performance

Historical Comparison
PSNY
STOK

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: